Psychedelic medicines make headlines for indications like PTSD, depression, and anxiety, but they’re being studied for a much broader range of conditions. The...
The article Palo Santo Closes $50 Million Psychedelic Investment Fund was originally published on Microdose. Palo Santo Closes $50 Million Psychedelic...
Relmada Therapeutics, Inc. (Nasdaq: RLMD), a late-stage biotechnology company addressing diseases of the central nervous system (CNS), today announced...
Clairvoyant Therapeutics, a Canadian biotech company focused on the development of psychedelic drug therapies for the treatment of addiction, is pleased...
A new analysis of old data suggests that the endangered erect-crested penguin’s bizarre nesting habits – rejecting the first egg they lay – is because...
The article Breaking News: Compass Pathways to run TWO Phase 3 Trials for Depression was originally published on Microdose. Today, psychedelic medicine...
Enveric Biosciences (NASDAQ: ENVB), a biotechnology company dedicated to the development of novel small-molecule therapeutics for the treatment of anxiety,...
The article Convergence Partners Invests in Psychedelic CRO Clerkenwell Health was originally published on Microdose. Convergence Partners invests...
The longest-running annual psychedelic conference is coming up this week, with a packed 4-day agenda featuring classes and panels around psychedelic medicine,...
That title has an ironic ring to it, doesn’t it? Psychedelics once sparked one of the biggest movements of peace that this world has ever known....